Concepedia

Daqing Sun

DS

43

Publications

2.2K

Citations

23

H-Index

1995

Active since

Affiliations

Amgen (United States)(Current)

Tianjin Medical University General Hospital

Nankai University

Daqing Sun is an author at Amgen (United States) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1995–2024

43

Publications

43

Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors

Daqing Sun, Linda C. Samuelson, Tianxin Yang et al. · Proceedings of the National Academy of Sciences · 2001 · 404 citations · Full text

, , +22

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 290 citations · Full text

Megakaryocyte growth and development factor ameliorates carboplatin- induced thrombocytopenia in mice

TR Ulich, Juan González del Castillo, Shuangyi Yin et al. · Blood · 1995 · 198 citations · Full text

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 166 citations · Full text

Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer

Tingting Wang, Xufang Chen, Wei‐Wei Qiao et al. · BMC Cancer · 2017 · 102 citations · Full text

Rows per page

1–5 of 43